{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Catechins", "EGC", "EGCG", "Green tea", "Inflammation", "Rheumatoid arthritis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28532672", "DateCompleted": {"Year": "2017", "Month": "07", "Day": "31"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "05", "Day": "19"}], "Language": ["eng"], "ELocationID": ["10.1016/j.taap.2017.05.016", "S0041-008X(17)30210-7"], "Journal": {"ISSN": "1096-0333", "JournalIssue": {"Volume": "329", "PubDate": {"Year": "2017", "Month": "Aug", "Day": "15"}}, "Title": "Toxicology and applied pharmacology", "ISOAbbreviation": "Toxicol Appl Pharmacol"}, "ArticleTitle": "Molecular insights into the differences in anti-inflammatory activities of green tea catechins on IL-1\u03b2 signaling in rheumatoid arthritis synovial fibroblasts.", "Pagination": {"StartPage": "112", "EndPage": "120", "MedlinePgn": "112-120"}, "Abstract": {"AbstractText": ["In this study, we found that catechins found in green tea (EGCG, EGC, and EC) differentially interfere with the IL-1\u03b2 signaling pathway which regulates the expression of pro-inflammatory mediators (IL-6 and IL-8) and Cox-2 in primary human rheumatoid arthritis synovial fibroblasts (RASFs). EGCG and EGC inhibited IL-6, IL-8, and MMP-2 production and selectively inhibited Cox-2 expression. EC did not exhibit any inhibitory effects. When we looked at the expression of key signaling proteins in the IL-1\u03b2 signaling pathway, we found all the tested catechins could inhibit TAK-1 activity. Therefore, the consumption of green tea offers an overall anti-inflammatory effect. Molecular docking analysis confirms that EGCG, EGC, and EC all occupy the active site of the TAK1 kinase domain. However, EGCG occupies the majority of the TAK1 active site. In addition to TAK1 inhibition, EGCG can also inhibit P38 and nuclear NF-\u03baB expression whereas EC and EGC were not effective inhibitors. Our findings suggest one of the main health benefits associated with the consumption of green tea are due to the activity of EGCG and EGC which are both present at higher amounts. Although EGCG is the most effective catechin at inhibiting downstream inflammatory signaling, its effectiveness could be hindered by the presence of EC. Therefore, varying EC content in green tea may reduce the anti-inflammatory effects of other potential catechins in green tea."], "CopyrightInformation": "Copyright \u00a9 2017. Published by Elsevier Inc."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA, USA."}], "LastName": "Fechtner", "ForeName": "Sabrina", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA, USA."}], "LastName": "Singh", "ForeName": "Anil", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacoinformatics, National lnstitute of Pharmaceutical Education and Research, Hajipur, Bihar, India."}], "LastName": "Chourasia", "ForeName": "Mukesh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA, USA. Electronic address: salah.ahmed@wsu.edu."}], "LastName": "Ahmed", "ForeName": "Salahuddin", "Initials": "S"}], "GrantList": [{"GrantID": "R01 AR063104", "Acronym": "AR", "Agency": "NIAMS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Toxicol Appl Pharmacol", "NlmUniqueID": "0416575", "ISSNLinking": "0041-008X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antirheumatic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "CXCL8 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclooxygenase 2 Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "IL1B protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "IL6 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-1beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-6"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-8"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Kinase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Proteins c-jun"}, {"RegistryNumber": "0", "NameOfSubstance": "Tea"}, {"RegistryNumber": "8R1V1STN48", "NameOfSubstance": "Catechin"}, {"RegistryNumber": "BQM438CTEL", "NameOfSubstance": "epigallocatechin gallate"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "p38 Mitogen-Activated Protein Kinases"}, {"RegistryNumber": "EC 2.7.11.25", "NameOfSubstance": "MAP Kinase Kinase Kinases"}, {"RegistryNumber": "EC 2.7.11.25", "NameOfSubstance": "MAP kinase kinase kinase 7"}, {"RegistryNumber": "EC 3.4.24.24", "NameOfSubstance": "MMP2 protein, human"}, {"RegistryNumber": "EC 3.4.24.24", "NameOfSubstance": "Matrix Metalloproteinase 2"}, {"RegistryNumber": "HEJ6575V1X", "NameOfSubstance": "gallocatechol"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antirheumatic Agents"}, {"QualifierName": ["drug therapy", "immunology", "metabolism"], "DescriptorName": "Arthritis, Rheumatoid"}, {"QualifierName": [], "DescriptorName": "Catalytic Domain"}, {"QualifierName": ["analogs & derivatives", "chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Catechin"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Cyclooxygenase 2 Inhibitors"}, {"QualifierName": ["drug effects", "immunology", "metabolism"], "DescriptorName": "Fibroblasts"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Interleukin-1beta"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-6"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-8"}, {"QualifierName": ["antagonists & inhibitors", "chemistry", "metabolism"], "DescriptorName": "MAP Kinase Kinase Kinases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Matrix Metalloproteinase 2"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Protein Kinase Inhibitors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-jun"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug effects", "immunology", "metabolism"], "DescriptorName": "Synovial Membrane"}, {"QualifierName": ["chemistry"], "DescriptorName": "Tea"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "p38 Mitogen-Activated Protein Kinases"}], "CoiStatement": "Conflicts of interest. No conflict of interest related to this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Lerner A, Jerem\u00edas P, Matthias T, 2015. The world incidence and prevalence of autoimmunediseases is increasing.lnt.J.Celiac Dis. 3 (4):151\u2013155 PubMed PMID. 10.12691/ijcd-3-4-8.", "ArticleIdList": ["10.12691/ijcd-3-4-8"]}, {"Citation": "Flannery S, Bowie AG, 2010. The interleukin-1 receptor-associated kinases: critical regulators ofinnate immune signalling. Biochem. Pharmacol. 80 (12):1981\u20131991. 10.1016/j.bcp.2010.06.020.", "ArticleIdList": ["10.1016/j.bcp.2010.06.020", "20599782"]}, {"Citation": "Boraschi D, Tagliabue A, 2013. The interleukin-1 receptor family. Semin. Immunol. 25 (6):394\u2013407. 10.1016/j.smim.2013.10.023.", "ArticleIdList": ["10.1016/j.smim.2013.10.023", "24246227"]}, {"Citation": "Crofford L, 2013. Prostanoid biology and its therapeutic targeting In: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O\u2019Dell JR (Eds.), Kelley\u2019s Textbook of Rheumatology. Saunders, Philadelphia."}, {"Citation": "Marsico F, Paolillo S, Perrone, Filardi P, 2016. NSAIDs and cardiovascular risk. J. Cardiovasc. Med. Epub 2016/09/23. 10.2459/jcm.0000000000000443 (PubMed PMID: ).", "ArticleIdList": ["10.2459/jcm.0000000000000443", "27652819"]}, {"Citation": "James M, Proudman S, Cleland L, 2010. Fish oil and rheumatoid arthritis: past, present and future. Proc. Nutr. Soc. 69 (3):316\u2013323 Epub 2010/06/01. 10.1017/s0029665110001564(PubMedPMID: ).", "ArticleIdList": ["10.1017/s0029665110001564", "20509981"]}, {"Citation": "Ribel-Madsen S, Bartels EM, Stockmarr A, Borgwardt A, Cornett C, Danneskiold-Samsoe B, Bliddal H, 2012. A synoviocyte model for osteoarthritis and rheumatoid arthritis: response to Ibuprofen, betamethasone, and ginger extract-a cross-sectional in vitro study. Arthritis 2012:505842 Epub 2013/02/01. 10.1155/2012/505842 (PubMed PMID: ; PMCID: Pmc3546442).", "ArticleIdList": ["10.1155/2012/505842", "PMC3546442", "23365744"]}, {"Citation": "Ahmed S, 2010. Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise. Arthritis Res. Ther. 12 (2):208 Epub 2010/05/08. 10.1186/ar2982 (PubMed PMID: ; PMCID: Pmc2888220).", "ArticleIdList": ["10.1186/ar2982", "PMC2888220", "20447316"]}, {"Citation": "Singh R, Akhtar N, Haqqi TM, 2010. Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. Life Sci. 86 (25\u201326):907\u2013918. 10.1016/j.lfs.2010.04.013 (PubMed PMID: ).", "ArticleIdList": ["10.1016/j.lfs.2010.04.013", "PMC3146294", "20462508"]}, {"Citation": "Chowdhury A, Sarkar J, Chakraborti T, Pramanik PK, Chakraborti S, 2016. \nProtective role ofepigallocatechin-3-gallate in health and disease: a perspective. Biomed. Pharmacother. 78:50\u201359. http://dx.doi.org/10.1016Zj.biopha.2015.12.013.", "ArticleIdList": ["26898424"]}, {"Citation": "Huo Y, Zhang Q, Li Q, Geng B, Bi K, 2016. Development of a UFLC-MS/MS method for the simultaneous determination of seven tea catechins in rat plasma and its application to a pharmacokinetic study after administration of green tea extract. J. Pharm. Biomed. Anal. 125:229\u2013235. 10.1016/jjpba.2016.03.048.", "ArticleIdList": ["10.1016/jjpba.2016.03.048", "27037979"]}, {"Citation": "Ahmed S, Pakozdi A, Koch AE, 2006. Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 54 (8):2393\u20132401 Epub 2006/07/27. 10.1002/art.22023 (PubMed PMID: ).", "ArticleIdList": ["10.1002/art.22023", "16869002"]}, {"Citation": "Ahmed S, Marotte H, Kwan K, Ruth JH, Campbell PL, Rabquer BJ, Pakozdi A, Koch AE, 2008. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proc. Natl. Acad. Sci. 105 (38), 14692\u201314697.", "ArticleIdList": ["PMC2567200", "18796608"]}, {"Citation": "Singh AK, Umar S, Riegsecker S, Chourasia M, Ahmed S, 2016. Regulation of TAK1 activation by epigallocatechin-3-gallate in RA synovial fibroblasts: Suppression of K63-linked autoubiquitination of TRAF6. Arthritis Rheumatol. Epub 2016/10/17.10.1002/art.39447 (PubMed PMID: ).", "ArticleIdList": ["10.1002/art.39447", "PMC5383419", "26473505"]}, {"Citation": "Wu J, Powell F, Larsen NA, Lai Z, Byth KF, Read J, Gu R-F, Roth M, Toader D, Saeh JC, Chen H, 2012. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-oxozeaenol. ACS Chem. Biol. 8 (3):643\u2013650. 10.1021/cb3005897", "ArticleIdList": ["10.1021/cb3005897", "23272696"]}, {"Citation": "Ninomiya-Tsuji J, Kajino T, Ono K, Ohtomo T, Matsumoto M, Shiina M, Mihara M, Tsuchiya M, Matsumoto K, 2003. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J. Biol. Chem. 18485\u201318490 (United States).", "ArticleIdList": ["12624112"]}, {"Citation": "Egg D, 1984. Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis. Z. Rheumatol. 43 (2), 89\u201396 (Epub 1984/03/01. PubMed PMID: ).", "ArticleIdList": ["6730731"]}, {"Citation": "Myers LK, Kang AH, Postlethwaite AE, Rosloniec EF, Morham SG, Shlopov BV, Goorha S, Ballou LR, 2000. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum. 43 (12), 2687\u20132693 (Epub 2001/01/06. doi: 10.1002/1529-0131(200012)43:12<2687::aid-anr8>3.0.co;2-9. PubMed PMID: ).", "ArticleIdList": ["10.1002/1529-0131(200012)43:12<2687::aid-anr8>3.0.co;2-9", "11145026"]}, {"Citation": "Ahmed S, Rahman A, Hasnain A, Lalonde M, Goldberg VM, Haqqi TM, 2002. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic. Biol. Med. 33 (8), 1097\u20131105 (Epub 2002/10/11. PubMed PMID: ).", "ArticleIdList": ["12374621"]}, {"Citation": "Huang GS, Tseng CY, Lee CH, Su SL, Lee HS, 2010. Effects of (\u2014)-epigallocatechin-3-gallate on cyclooxygenase 2, PGE(2), and IL-8 expression induced by IL-1beta in human synovial fibroblasts. Rheumatol. Int. 30 (9):1197\u20131203 Epub 2009/09/25. 10.1007/s00296-009-1128-8 (PubMedPMID: ).", "ArticleIdList": ["10.1007/s00296-009-1128-8", "19777241"]}, {"Citation": "Hawkey CJ, 1999. COX-2 inhibitors. Lancet 353 (9149):307\u2013314. 10.1016/S0140-6736(98)12154-2.", "ArticleIdList": ["10.1016/S0140-6736(98)12154-2", "9929039"]}, {"Citation": "Fechtner S, Fox DA, Ahmed S, 2016. Transforming growth factor beta activated kinase 1: a potential therapeutic target for rheumatic diseases. Rheumatology Epub 2016/ 08/2410.1093/rheumatology/kew301 (PubMedPMID: ).", "ArticleIdList": ["10.1093/rheumatology/kew301", "PMC5850516", "27550296"]}, {"Citation": "Bigelow RL, Cardelli JA, 2006. The green tea catechins, (\u2014)-epigallocatechin-3-gallate (EGCG) and (\u2212)-epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene 25 (13):1922\u20131930 Epub 2006/02/02.10.1038/sj.onc.1209227 (PubMed PMID: ).", "ArticleIdList": ["10.1038/sj.onc.1209227", "16449979"]}, {"Citation": "Du GJ, Zhang Z, Wen XD, Yu C, Calway T, Yuan CS, Wang CZ, 2012. Epigallocate-chin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients 4 (11):1679\u20131691 Epub 2012/12/04. 10.3390/nu4111679 (PubMed PMID: ; PMCID: PMC3509513).", "ArticleIdList": ["10.3390/nu4111679", "PMC3509513", "23201840"]}, {"Citation": "Sachinidis A, Skach RA, Seul C, Ko Y, Hescheler J, Ahn HY, Fingerle J, 2002. Inhibition of the PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins. FASEBJ. 16 (8):893\u2013895 Epub 2002/06/01. 10.1096/fj.01-0799fje (PubMed PMID: ).", "ArticleIdList": ["10.1096/fj.01-0799fje", "12039871"]}, {"Citation": "Chow HHS, Hakim IA, Vining DR, Crowell JA, Ranger-Moore J, Chew WM, Celaya CA, Rodney SR, Hara Y, Alberts DS, 2005. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals. Clin. Cancer Res. 11 (12):4627 10.1016/j.tox.2009.03007 Epub 2009 Mar 24. (PubMed PMID: ).", "ArticleIdList": ["10.1016/j.tox.2009.03007", "15958649"]}, {"Citation": "Henning SM, Fajardo-Lira C, Lee HW, Youssefian AA, Go VL, Heber D, 2003. Catechin content of18 teas and a green tea extract supplement correlates with the antioxidant capacity. Nutr. Cancer 45 (2):226\u2013235 Epub 2003/07/26. 10.1207/s15327914nc4502_13 (PubMed PMID: ).", "ArticleIdList": ["10.1207/s15327914nc4502_13", "12881018"]}, {"Citation": "Khokhar S, Magnusdottir SG, 2002. Total phenol, catechin, and caffeine contents of teas commonly consumed in the United kingdom. J. Agric. Food Chem. 50 (3), 565\u2013570 Epub 2002/01/24. (PubMed PMID: ).", "ArticleIdList": ["11804530"]}, {"Citation": "Schr\u00f6dinger Release 2015\u20132, 2015a. LigPrep, version 3.4. Schr\u00f6dinger, LLC, New York, NY."}, {"Citation": "Schr\u00f6dinger Release 2015\u20132, 2015b. Desmond Molecular Dynamics System, version 4.2. D. E. Shaw Research, New York, NY."}]}], "History": [{"Year": "2016", "Month": "12", "Day": "8"}, {"Year": "2017", "Month": "5", "Day": "11"}, {"Year": "2017", "Month": "5", "Day": "16"}, {"Year": "2017", "Month": "5", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "5", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28532672", "NIHMS1044059", "PMC6686859", "10.1016/j.taap.2017.05.016", "S0041-008X(17)30210-7"]}}]}